Michelle Renee Griffin, Director at Adaptive Biotechnologies Corp (ADPT), sold 9,609 shares at $47.00 ($410K) on 2021-03-16, disclosed to the SEC on 2021-03-17.
Open-market sale of $410k ADPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.17 | 891 | $37K | 9.0% |
| 2 | $41.89 | 3,609 | $151K | 36.9% |
| 3 | $41.89 | 3,609 | $151K | 36.9% |
| 4 | $47.00 | 1,500 | $71K | 17.2% |
| Total | $42.62 avg | 9,609 | $410K | 100% |
| Filing → |
| ADPT | SELL | 2026-03-05 | $735K | — | Filing → |
| ADPT | SELL | 2025-03-17 | $522K | — | Filing → |
| ADPT | SELL | 2025-03-06 | $249K | — | Filing → |